search
Back to results

Visceral (Kidney and Abdominal Organ) Function After Fenestrated and Branched Endovascular Aneurysm Repair (FEVAR/BEVAR) of Thoracoabdominal Aortic Aneurysms

Primary Purpose

Aortic Aneurysm, Abdominal

Status
Enrolling by invitation
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Endovascular repair of thoracoabdominal aortic aneurysm (TAAA) using branched stent graft
Sponsored by
University of North Carolina, Chapel Hill
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Aortic Aneurysm, Abdominal focused on measuring Aortic Aneurysm, abdominal

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

Patients may be included in the study if the patient has at least one of the following and has aortic anatomy appropriate for treatment with the Zenith® p-Branch™, Zenith® t-Branch, or Physician Specified TAAA Endovascular Graft (Custom Manufactured Devices).

  1. Aortic Aneurysm Diameter

    1. TAAA (Type I - IV) (including pararenal subtypes) with orthogonal aortic diameter greater than or equal to 5 cm or
    2. greater than two times the normal aortic diameter
  2. Rapid aortic enlargement (> than or equal to 5mm in 1 year)
  3. Presence of a saccular aneurysm at risk for rupture based on investigators evaluation
  4. Iliac artery aneurysm ˃2.2 cm may be treated with the Zenith® Branch Endovascular Graft-Iliac Bifurcation when the iliac artery aneurysm is associated with the qualifying thoracoabdominal aneurysm treated in this study

Exclusion Criteria:

General Exclusion Criteria

Patients must be excluded from the study if any of the following conditions are true:

  1. Less than 18 years of age
  2. Unwilling to comply with the follow-up schedule
  3. Inability or refusal to give informed consent

Medical Exclusion Criteria

Patients must be excluded from the study if any of the following conditions are true:

  1. Known sensitivities or allergies to stainless steel, nitinol, polyester, solder (tin, silver), polypropylene, urethane or gold
  2. History of anaphylactic reaction to contrast material that cannot be adequately premedicated
  3. Leaking, ruptured aneurysm associated with hypotension
  4. Uncorrectable coagulopathy

Anatomical Exclusion Criteria

Patients must be excluded from the study if any of the following conditions are true:

  1. Inadequate femoral/iliac access compatible with the required delivery systems;
  2. Does not have a non-aneurysmal aortic segment proximal to the aneurysm with:

    1. A length of at least 4 mm, i.e. at least 4 mm circumferential wall contact around the limits of scallop
    2. A diameter measured outer wall to outer wall of no greater than 31mm and no less than 21 mm;
    3. An angle less than 60 degrees relative to the centerline of the aneurysm;
    4. An angle less than 45 degrees relative to the supraceliac aorta.
  3. Does not have visceral vessel anatomy compatible with Zenith® p-Branch™, specifically:

    1. Renal vessel origins as measured relative to the superior mesenteric artery (SMA) compatible with the renal fenestration, i.e. Both renal vessel origins within 7.5mm of the corresponding renal fenestrations;
    2. Celiac vessel origin as measured relative to the superior mesenteric artery (SMA) compatible with the celiac scallop.
  4. A proximal seal site with unsuitable thrombus/atheroma
  5. Does not have iliac artery fixation sites and anatomy consistent with:

    1. Common iliac artery fixation site diameter, measured outer wall to outer wall on a sectional image (CT) <8.0 mm (prior to deployment)
    2. Iliac artery diameter, measured outer wall to outer wall on a sectional image (CT) >21 mm at distal fixation site
    3. Iliac artery distal fixation site <10 mm in length
    4. Inability to preserve at least one hypogastric artery

      -

      -

Sites / Locations

  • UNC Heart and Vascular

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

endovascular repair TAAA

Arm Description

Endovascular repair of thoracoabdominal aortic aneurysm (TAAA) using Branched stent grafts

Outcomes

Primary Outcome Measures

Change from baseline in renal function over time (up to two years) after endovascular aortic aneurysm repair various custom stent grafts
Visceral function after endovascular repair of pararenal aneurysms using various custom stent grafts. Specifically, the device orientation and configuration will be evaluated with respect to renal function over time. Critical data concerning each branched vessel from radiological studies coupled with hemodynamic data obtained from renal artery duplex, changes in renal volume, eGFR, and flow characteristics at 1, 6, 12, 18 and 24 months post procedure may make it possible to determine changes in renal function.

Secondary Outcome Measures

Time to morbidity
Morbidity at 30 days, 1 & 2 years post procedure
Time to mortality
Mortality at 30 days, 1 & 2 years post procedure.
Time to loss of stent graft integrity
Evidence on contrast CT angiography of loss of stent graft integrity at 30 days, and one and two years post procedure.
Time to migration
Evidence of stent graft migration on abdominal x-rays at 30 days and 1 & 2 years.
Endoleak
Evidence of Endoleak on contrast CT angiography of abdomen 30 days and 1 & 2 years post procedure.
Branch vessel Events
Evidence of branch vessel events on contrast CT angiography and renal duplex 30 days, and 1 & 2 years post procedure.

Full Information

First Posted
July 27, 2012
Last Updated
March 21, 2023
Sponsor
University of North Carolina, Chapel Hill
Collaborators
UNC Hospitals, Cook Group Incorporated
search

1. Study Identification

Unique Protocol Identification Number
NCT01654133
Brief Title
Visceral (Kidney and Abdominal Organ) Function After Fenestrated and Branched Endovascular Aneurysm Repair (FEVAR/BEVAR) of Thoracoabdominal Aortic Aneurysms
Official Title
Evaluation of Visceral Function Following Fenestrated Endovascular Aortic Aneurysm Repair (FEVAR) Using Branch Stent-Grafts
Study Type
Interventional

2. Study Status

Record Verification Date
March 2023
Overall Recruitment Status
Enrolling by invitation
Study Start Date
July 2012 (undefined)
Primary Completion Date
August 2030 (Anticipated)
Study Completion Date
August 2030 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of North Carolina, Chapel Hill
Collaborators
UNC Hospitals, Cook Group Incorporated

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study is to evaluate visceral function, after endovascular repair of thoracoabdominal aneurysms.
Detailed Description
This study will evaluate the effect of endovascular repair of thoracoabdominal aortic aneurysms (Types I-IV) on visceral function using custom manufactured and off the shelf stent grafts. Specifically, the device orientation and configuration will be evaluated with respect to renal function. Since detailed CT scan imaging will be performed prior to and after endovascular repair, critical data concerning each branched vessel length, tangential orientation from the aorta, angle of incidence, and diameter can be determined. This information can then be coupled with hemodynamic data obtained from duplex ultrasonography as well as changes in renal volume, estimated glomerular filtration rate (eGFR), and flow characteristics over time. By analyzing the data in this fashion, it may be possible to determine changes in hemodynamics and/or physiologic conditions with respect to branched stent-graft design characteristics. These data may be utilized to enhance current device design and improve patient outcomes. The FDA has approved the use of commercially available devices to be used in conjunction with the investigational device if the Investigator deems this necessary.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Aortic Aneurysm, Abdominal
Keywords
Aortic Aneurysm, abdominal

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
500 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
endovascular repair TAAA
Arm Type
Experimental
Arm Description
Endovascular repair of thoracoabdominal aortic aneurysm (TAAA) using Branched stent grafts
Intervention Type
Device
Intervention Name(s)
Endovascular repair of thoracoabdominal aortic aneurysm (TAAA) using branched stent graft
Other Intervention Name(s)
Endovascular repair of thoracoabdominal aortic aneurysm
Intervention Description
Repair of thoracoabdominal aortic aneurysms
Primary Outcome Measure Information:
Title
Change from baseline in renal function over time (up to two years) after endovascular aortic aneurysm repair various custom stent grafts
Description
Visceral function after endovascular repair of pararenal aneurysms using various custom stent grafts. Specifically, the device orientation and configuration will be evaluated with respect to renal function over time. Critical data concerning each branched vessel from radiological studies coupled with hemodynamic data obtained from renal artery duplex, changes in renal volume, eGFR, and flow characteristics at 1, 6, 12, 18 and 24 months post procedure may make it possible to determine changes in renal function.
Time Frame
Pre-procedure and 1, 6, 12, 18, and 24 months post procedure
Secondary Outcome Measure Information:
Title
Time to morbidity
Description
Morbidity at 30 days, 1 & 2 years post procedure
Time Frame
30 days and 1 & 2 years post procedure
Title
Time to mortality
Description
Mortality at 30 days, 1 & 2 years post procedure.
Time Frame
30 days and 1 & 2 years post procedure
Title
Time to loss of stent graft integrity
Description
Evidence on contrast CT angiography of loss of stent graft integrity at 30 days, and one and two years post procedure.
Time Frame
30 days and 1 & 2 years post procedure
Title
Time to migration
Description
Evidence of stent graft migration on abdominal x-rays at 30 days and 1 & 2 years.
Time Frame
30 days and 1 & 2 years post procedure
Title
Endoleak
Description
Evidence of Endoleak on contrast CT angiography of abdomen 30 days and 1 & 2 years post procedure.
Time Frame
30 days and 1 & 2 years post procedure
Title
Branch vessel Events
Description
Evidence of branch vessel events on contrast CT angiography and renal duplex 30 days, and 1 & 2 years post procedure.
Time Frame
30 days and 1 & 2 years post procedure

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients may be included in the study if the patient has at least one of the following and has aortic anatomy appropriate for treatment with the Zenith® p-Branch™, Zenith® t-Branch, or Physician Specified TAAA Endovascular Graft (Custom Manufactured Devices). Aortic Aneurysm Diameter TAAA (Type I - IV) (including pararenal subtypes) with orthogonal aortic diameter greater than or equal to 5 cm or greater than two times the normal aortic diameter Rapid aortic enlargement (> than or equal to 5mm in 1 year) Presence of a saccular aneurysm at risk for rupture based on investigators evaluation Iliac artery aneurysm ˃2.2 cm may be treated with the Zenith® Branch Endovascular Graft-Iliac Bifurcation when the iliac artery aneurysm is associated with the qualifying thoracoabdominal aneurysm treated in this study Exclusion Criteria: General Exclusion Criteria Patients must be excluded from the study if any of the following conditions are true: Less than 18 years of age Unwilling to comply with the follow-up schedule Inability or refusal to give informed consent Medical Exclusion Criteria Patients must be excluded from the study if any of the following conditions are true: Known sensitivities or allergies to stainless steel, nitinol, polyester, solder (tin, silver), polypropylene, urethane or gold History of anaphylactic reaction to contrast material that cannot be adequately premedicated Leaking, ruptured aneurysm associated with hypotension Uncorrectable coagulopathy Anatomical Exclusion Criteria Patients must be excluded from the study if any of the following conditions are true: Inadequate femoral/iliac access compatible with the required delivery systems; Does not have a non-aneurysmal aortic segment proximal to the aneurysm with: A length of at least 4 mm, i.e. at least 4 mm circumferential wall contact around the limits of scallop A diameter measured outer wall to outer wall of no greater than 31mm and no less than 21 mm; An angle less than 60 degrees relative to the centerline of the aneurysm; An angle less than 45 degrees relative to the supraceliac aorta. Does not have visceral vessel anatomy compatible with Zenith® p-Branch™, specifically: Renal vessel origins as measured relative to the superior mesenteric artery (SMA) compatible with the renal fenestration, i.e. Both renal vessel origins within 7.5mm of the corresponding renal fenestrations; Celiac vessel origin as measured relative to the superior mesenteric artery (SMA) compatible with the celiac scallop. A proximal seal site with unsuitable thrombus/atheroma Does not have iliac artery fixation sites and anatomy consistent with: Common iliac artery fixation site diameter, measured outer wall to outer wall on a sectional image (CT) <8.0 mm (prior to deployment) Iliac artery diameter, measured outer wall to outer wall on a sectional image (CT) >21 mm at distal fixation site Iliac artery distal fixation site <10 mm in length Inability to preserve at least one hypogastric artery - -
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mark A Farber, MD
Organizational Affiliation
University of North Carolina, Chapel Hill, NC 27599
Official's Role
Principal Investigator
Facility Information:
Facility Name
UNC Heart and Vascular
City
Chapel Hill
State/Province
North Carolina
ZIP/Postal Code
27599
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Visceral (Kidney and Abdominal Organ) Function After Fenestrated and Branched Endovascular Aneurysm Repair (FEVAR/BEVAR) of Thoracoabdominal Aortic Aneurysms

We'll reach out to this number within 24 hrs